| PERIOD ENDING | 31-Jul-09 | 30-Apr-09 | 31-Jan-09 | 31-Oct-08 | | Total Revenue | 275,505 | 2,466,753 | 993,446 | 283,740 | | Cost of Revenue | 386,450 | 1,106,566 | 684,567 | 392,656 | | | Gross Profit | (110,945) | 1,360,187 | 308,879 | (108,916) | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 103,217 | 184,436 | 208,814 | 114,770 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (214,162) | 1,175,751 | 100,065 | (223,686) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 3,289 | 2,303 | 1,674 | (2,121) | | Earnings Before Interest And Taxes | (210,873) | 1,178,054 | 101,739 | (225,807) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (210,873) | 1,178,054 | 101,739 | (225,807) | | Income Tax Expense | (80,256) | 470,245 | 34,909 | (93,592) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (130,617) | 707,809 | 66,830 | (132,215) | | | Non-recurring Events | | Discontinued Operations | (3,017) | (906) | (19,467) | (3,659) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (133,634) | 706,903 | 47,363 | (135,874) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($133,634) | $706,903 | $47,363 | ($135,874) |
|
0.17% Nasdaq 
Income Statement
